Saturday, 24 October 2020 22:00–22:50: POSTER DISCUSSION SESSION: Cancer Therapeutics: Preclinical Modeling and Patient Stratification| Volume 138, SUPPLEMENT 2, S18, October 2020

MatchMiner: Computational matching of cancer patients to precision medicine clinical trials

      To facilitate interpretation of complex tumor sequencing data and clinical trial genomic eligibility criteria, we developed MatchMiner, an open-source platform to computationally match cancer patients to precision medicine clinical trials based on clinical and genomic features. MatchMiner enables physicians to identify clinical trial options for individual patients and enables clinical trial investigators to identify patients eligible for genomically-driven trials. MatchMiner can also be used to display profiling reports, independent of trial matching.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect